Mika Ilves

3.2k citations
47 papers · 2.5k indexed · 1 hit paper · h-index 26

Mika Ilves

47 papers receiving 2.4k citations

Hit Papers

Apelin, the Novel Endogenous Ligand of the Orphan Recepto...20022026201020182002100200300400500

Peers

Mika Ilves
Comparison fields: 5 of 100
  • Molecular Biology 975
  • Surgery 790
  • Pharmacology 709
  • Cardiology and Cardiovascular Medicine 641
  • Cellular and Molecular Neuroscience 480
Replace Wataru Nishida with:
Wataru Nishida Japan
Leonardo Guasti United Kingdom
Laurent Muller France
Pablo Martı́n-Vasallo Spain
S. Kumar United Kingdom
Marjorie Maillet United States
Catherine Monnot France
Patrick A. Dreyfus France
Atsushi Ishida Japan
Chantal Chenu France
Mika Ilves relative to Wataru Nishida Japan Wataru Nishida's profile →
Citations per field
00.5×5.6×
Wataru Nishida · 1×
Citations per year

Countries citing papers authored by Mika Ilves

Since Specialization
Citations

This map shows the geographic impact of Mika Ilves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika Ilves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika Ilves more than expected).

Fields of papers citing papers by Mika Ilves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika Ilves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika Ilves. The network helps show where Mika Ilves may publish in the future.

Co-authorship network of co-authors of Mika Ilves

This figure shows the co-authorship network connecting the top 25 collaborators of Mika Ilves. A scholar is included among the top collaborators of Mika Ilves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika Ilves. Mika Ilves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 15
3 21
4 19
5 87
6 16
7 53
8 15
9 56
10 33
11 18
12 30
13 33
14 9
15 45
16 29
17 218
18 20
19 59
20 68

About Mika Ilves

Mika Ilves is a scholar working on Immunology and Allergy, Equine and Cardiology and Cardiovascular Medicine, having authored 47 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (12 papers), Signaling Pathways in Disease (7 papers) and Cell Adhesion Molecules Research (7 papers). The work is most often cited by research in Pharmacology (709 citations), Immunology and Allergy (184 citations) and Cardiology and Cardiovascular Medicine (641 citations). Mika Ilves has collaborated with scholars based in Finland, Hungary and United Kingdom. Frequent co-authors include Heikki Ruskoaho, Jaana Rysä, Olli Vuolteenaho, István Szokodi, Jarkko Piuhola, Hanna Leskinen, Gábor Földes, Sampsa Pikkarainen, Heikki Tokola and Juhani Leppäluoto. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026